Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 16137 articles
Multi-dimensional profiling of lactylation-related signatures for prognostic and therapeutic insights in bladder cancer
Significant increase of pan-lysine lactylation (Pan-kla) in BCa.
»
06/06/26
Sex differences in gastric cancer mutational burden reflect MLH1-associated epigenetic regulation
Female-associated TMB elevation partly related to increased representation of MSI/MMR-deficient tumors.
»
06/15/26
In vitro functional analysis of lysyl oxidase family members in highly metastatic pancreatic cancer cells derived from a syngeneic orthotopic model
Panc02-3P cells exhibited mesenchymal-like gene expression changes.
»
06/15/26
ZEB1 integrates stemness, differentiation blockade and immune suppression to orchestrate osteosarcoma aggressiveness
ZEB1 deletion in mouse OS cells significantly hindered tumor growth and lung metastasis.
»
06/15/26
Predicting the region of tumor micro-infiltration in glioblastoma peritumoral edema using a multiparametric mri radiomics model
TMI prediction model had overall accuracy of 81.25%.
»
06/15/26
Trajectory and predictors of cancer- and treatment-related fatigue (CRF) in adolescent and young adult cancer patients: a prospective, longitudinal study
Measurements collected during active chemotherapy had a higher rate of clinically important CRF symptoms.
»
06/16/26
An integrative framework combining Mendelian randomization, single-cell profiling, and experimental validation identifies FTMT as a mitochondrial–immune regulator in non-small cell lung cancer
Genetically predicted higher FTMT levels associated with reduced NSCLC risk.
»
06/16/26
Final analysis of phase 2 clinical trial of ruxolitinib and azacitidine combination therapy in patients with myelodysplastic syndrome/myeloproliferative neoplasms
AZA-RUX therapy led to durable responses.
»
06/16/26
BRD4 regulation of PIM1 identifies a novel therapeutic vulnerability in acute megakaryoblastic leukemia
BRD4 expression significantly elevated in AMKL.
»
06/17/26
Vascular and mesenchymal signatures of breast cancers associated with Yo and Ri paraneoplastic syndrome
Increased podoplanin-positive lymphatic structures in both Yo-BCs and Ri-BCs.
»
06/17/26
< Prev
Next >